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Background: Peritoneal dialysis (PD) therapy is known to induce morphological and functional changes in the
peritoneal membrane. Long-term exposure to conventional bio-incompatible dialysate and peritonitis is the main
etiology of inflammation. Consequently, the peritoneal membrane undergoes structural changes, including
angiogenesis, fibrosis, and hyalinizing vasculopathy, which ultimately results in technique failure. The epithelial-
to-mesenchymal transition (EMT) of mesothelial cells (MCs) plays an important role during the above process;
however, the clinical parameters associated with the EMT process of MCs remain to be explored.
Methods: To investigate the parameters impacting EMT during PD therapy, 53 clinical stable PD patients were
enrolled. EMT assessments were conducted through human peritoneal MCs cultured from dialysate effluent with
one consistent standard criterion (MC morphology and the expression of an epithelial marker, cytokeratin 18).
The factors potentially associated with EMT were analyzed using logistic regression analysis. Primary MCs
derived from the omentum were isolated for the in vitro study.
Results: Forty-seven percent of the patients presented with EMT, 28% with non-EMT, and 15% with a mixed
presentation. Logistic regression analysis showed that patients who received persistent PD therapy (dwelling
time of 24 h/day) had significantly higher EMT tendency. These results were consistent in vitro.
Conclusions: Dwelling time had a significant effect on the occurrence of EMT on MCs.
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In recent decades, peritoneal dialysis (PD) has been used
as a therapy for end-stage renal disease (ESRD) and has
been shown to provide equivalent adequacy and similar
mortality rates to those of hemodialysis (HD) [1,2]. How-
ever, 5- and 10-year technique survival rates are only
about 70% and 50%, respectively [3-5]. The main causes of
treatment failure are the development of recurrent peri-
tonitis, loss of residual renal function, inadequate solute
clearance, and loss of peritoneal membrane function [3].* Correspondence: yuanyow@mail.ncku.edu.tw
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reproduction in any medium, provided the orThere have been many advances in PD technique;
however, ways to prevent the loss of peritoneal mem-
brane function are still not fully understood. Continuous
exposure to conventional bio-incompatible dialysate,
which is acidic and contains large amounts of glucose
degradation products (GDPs), is now thought to be one
of the main causes of peritoneal morphological and
functional deterioration [6,7]. After undergoing PD, pa-
tients present with a reduction of microvilli, epithelial-
to-mesenchymal transition (EMT) of mesothelial cells
(MCs), sub-mesothelial fibrosis, and microvasculature
disorders [8-10]. Consequently, the efficiency of dialysis
decreases and leads to PD failure [11].
The EMT of MCs plays an important role in this patho-
physiology [12]. After dialysis, peritoneal MCs initiate the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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phenotype, and they acquire a myofibroblast-like mor-
phology [10,13]. Then, those MCs contribute to peritoneal
angiogenesis and fibrosis, two main causes of PD failure
[10,12]. Therefore, the EMT may be a key factor in peri-
toneal alterations during PD. However, there is limited in-
formation and no consistent result regarding the clinical
parameters associated with EMT in previous studies
[10,12,14-18]. Moreover, classifying EMT only according
to morphology is subjective and unreliable.
The aims of this study were to determine the clinical
factors associated with the EMT in PD patients and then
to explore potential therapeutic interventions.
Methods
Patients and mesothelial cells
MCs from effluents were obtained by centrifugation of
dialysis fluid taken from PD patients who were stable
and regularly followed-up at an outpatient department be-
tween January 2010 and March 2011 [8,19]. To standardize
MC collected from effluent, we obtained the cells using
standard protocol (dwelling time 4 hours with 2.5% glu-
cose). The purity of the MCs was determined by the ex-
pression of intercellular adhesion molecule-1 (ICAM-1) [8].
Patients were excluded if they had inflammatory conditions
(including peritonitis), hemoperitoneum in the previousFigure 1 Flow chart of the study protocol.3 months, or poor compliance (Figure 1). Clinical charac-
teristics, including age, gender, body mass index (BMI), dia-
betes, hypertension, serum albumin, hemoglobin, residual
renal function (RRF), techniques (manual or automatic),
glucose loading, peritoneal dialysis duration, total duration
of dialysate exposure, dwelling time (Group 1: ranging from
8–20 h daily, Group 2: 24 h with conventional dialysate and
icodextrin-containing solution, and Group 3: 24 h with all
conventional dialysates), episodes of peritonitis, and use of
renin-angiotensin-aldosterone system (RAAS) inhibitors or
statins, were analyzed. Glucose load was calculated by the
total amount of glucose in each bag during the entire dialy-
sis period [12,16], and the total duration of dialysate expos-
ure was calculated by the sum of the dwelling time during
the entire time on PD. RAAS inhibitors included angioten-
sin converting enzyme inhibitors, angiotensin II receptor
blockers, and renin inhibitors. All patients were primarily
treated with a conventional dialysate, which contains high
glucose, lactate, and glucose degradation products (Dianeal;
Baxter), and some patients were also treated with
icodextrin-containing solution (Extraneal; Baxter). There
were no patients receiving neutral pH, low-GDP dialysate.
Subgroup classifications of peritoneal dialysis patients
Subgroup classifications for peritoneal dialysis patients
were according the MCs from their effluents. The
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Because classifying EMT only according to the morphology
of MCs from the effluents is subjective and unreliable, we
also checked the cytokeratin 18 (epithelial marker) expres-
sion in MCs. If the effluent MCs presented as epithelioid-
like and expressed cytokeratin 18 in more than 70% of the
effluent cells, the patient was assigned to the “Non-EMT”
group. If the morphology was fibroblast-like, and cytokera-
tin 18 expression was less than 70% of the effluent cells, the
patient was assigned to the “EMT” group. If the morpho-
logy was both epithelioid- and fibroblast-like with a double
peak in the flow cytometry profile for cytokeratin 18, the
patient was assigned to the “Mixed” group. The remaining
patients were assigned to the “Non-classified” group
(Figure 2). In addition, other EMT markers, including α-
smooth muscle actin (α-SMA), E-cadherin by Western
blotting and Phalloidin-labeled staining of MCs cyto-
skeletal actin were studied to validate the classification
criteria. The results were found to be consistent (data
not shown).
In vitro study design
To investigate the effects of daily dwelling time on the
EMT of MCs, primary MCs derived from the healthy
omentum donor were incubated with conventionalFigure 2 Classification of the epithelial-to-mesenchymal transition of
(EMT) was based on cellular morphology and surface markers. Mesothelial
were performed. Upper panel: Photomicrographs (×200) of the confluent
the MCs stained with cytokeratin 18 monoclonal antibodies. If the MC cell
of >70%, the patient was considered “Non EMT” (N = 15). If the morpholog
the patient was considered “EMT” (N = 25). If the cellular morphology was
the flow cytometry profile for cytokeratin 18, the patient was considered “dialysate, which was comprised of 4.25% glucose and lac-
tate (Dianeal; Baxter). The dialysate was diluted by one-
half of culture medium for 8, 16, or 24 h/day for 3 or
6 days (denoted as the “8 hours”, “16 hours” and “24 hours”
groups). To serve as a negative control, primary MCs were
treated with phosphate-buffered saline (PBS) and diluted
by one-half with culture medium. MC cultures that were
treated with culture medium containing human recom-
binant transforming growth factor-β1 (TGF-β1) (R&D
Systems Inc, Minneapolis, MN), (3 ng/mL) were regarded
to as positive controls [16] (Figure 3).
Flow cytometry and immunofluorescence
The purity of the MC from effluents and omentum
was determined by ICAM-1 expression (anti-ICAM-1;
eBioscience, San Diego, CA), and subgroup classifica-
tions of MCs from effluents were determined by cyto-
keratin 18 expression (anti-cytokeratin 18, Santa Cruz
Biotechnology, Santa Cruz, CA). Phalloidin-labeled stai-
ning was used to investigate the expression of MCs cyto-
skeletal actin as described previously [20].
Western blotting for E-cadherin
To validate the changes in EMT of MCs, the expression
of the epithelial marker, E-cadherin (anti-E-cadherin; BDmesothelium cells. Classification of epithelial-to-mesenchymal transition
cells (MCs) were collected from dialysate, and primary cell cultures
monolayers of the MCs. Lower panel: Flow-cytometric histograms of
ular morphology was epithelioid-like with a cytokeratin 18 expression
y appeared fibroblast-like, and cytokeratin 18 expression was <70%,
a mixture of epithelioid- and fibroblast-like and had a double peak in
Mixed” (N = 8).
Figure 3 An in vitro protocol to investigate the dwelling time on the effect of mesothelial cells. Primary mesothelial cells (MCs) were
incubated with conventional dialysate (4.25% glucose; Dianeal; Baxter) and diluted by one-half with culture medium for 8, 16, or 24 hours per day
for 3 or 6 days (denoted as “8 hours”, “16 hours”, and “24 hours” groups). Primary MCs incubated with phosphate-buffered saline (PBS) solution or
transforming growth factor-β1(TGF-β1) (3 ng/mL) served as the negative and positive controls, respectively. (dotted line: MCs were incubated with
PBS and equivalent dilution with culture medium; thin solid line: MCs were incubated with 4.25% glucose dialysate and equivalent dilution with
culture medium; thick solid line: MCs were incubated with TGF-β1 added in culture medium).
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were incubated with alkaline phosphatase-conjugated sec-
ondary antibodies (Sigma-Aldrich, San Luis, MO) to each
primary antibody and detected using enhanced chemilu-
minescence (Chemicon International, Billerica, MA).
Calculation of mesothelium cell count
The MC count was determined by repeated calculations
in a counting chamber to identify the rest of the surviving
cells.
Statistical analysis
Continuous data were expressed as mean ± S.D. P < 0.05
was considered to be statistically significant. The associa-
tions between patients’ clinical characteristics and factors
associated with the EMT of the MCs were analyzed using
a univariate logistic regression. Significant predictors (P <
0.2) in the univariate analyses and other possible factors
that may influence EMT of the MCs were included in the
multivariate analysis. Odds ratios (OR) with 95% confi-
dence intervals (CI) for each variable were used to esti-
mate the relative risk (RR) of EMT. Data of the in vitro
study were analyzed using nonparametric statistics. All ex-
perimental data were performed at least in triplicate. All
data were analyzed using SPSS statistical software package,
version 18 (SPSS Inc., Chicago, IL, USA).
Ethics statement
The study was approved by the ethics committee/institu-
tional review board of E-Da Hospital, and written informedconsent was obtained from all patients. (IRB number:
EMRP18100N).
Results
Effects of dwelling time on the EMT of MCs
All patients were primarily treated with a conventional
dialysate consisting of high glucose, lactate, and GDPs
concentrations (Dianeal; Baxter). Seventeen patients
(32%) were also treated with icodextrin-containing solu-
tion (Extraneal; Baxter) with one exchange/day. Thirty-
six (68%) patients received continuous PD therapy with
a dwelling time of 24 h, and the remaining 17 (32%) re-
ceived intermittent dialysis with a dwelling time ranging
from 8–20 h. The basic characteristics of the patients
are presented in Table 1. According to the standard cri-
teria, there were 15 patients assigned to the “Non-
EMT”, 25 to the “EMT”, and 8 to the “Mixed” groups.
There were 5 patients assigned to the “Non-classified”
group, as they did not meet any of the criteria. Univari-
ate ordinal logistic regression analysis revealed that only
age and shorter dwelling time could prevent EMT of
MCs (Table 2). After adjusting for age, diabetes, total
duration of dialysate exposure, and episodes of peritonitis
in the multivariate analysis, dwelling time still remained as
an independent (group 2 vs. 1: OR 7.37, 95% CI 1.35 to
40.20; group 3 vs. 1: OR 6.16, 95% CI 1.20 to 31.40; when
group 1 was the reference). In summary, the MCs of those
who received continuous dialysis with a daily dwelling
time of up to 24 h had a greater tendency of undergoing
the EMT process, and this tendency was not suppressed
by icodextrin-containing solution (one exchange/day).
Table 1 Basic characteristics of patients, according to presence of epithelial-to-mesenchymal transitioning
Variable Non-EMT group (N = 15) Mixed group (N = 8) EMT group (N = 25) P value
Age (years) 57.7 ± 14.7 57.4 ± 7.4 51.0 ± 9.1 0.17
Male, n (%) 7 (46.7) 6 (75) 15 (62.5%) 0.36
BMI (kg/m2) 23.0 ± 5.2 24.6 ± 3.6 24.5 ± 3.4 0.51
Diabetes mellitus (%) 10 (66.7%) 5 (62.5%) 10 (41.7%) 0.33
Hypertension (%) 14 (93.3%) 7 (87.5%) 19 (79.2%) 0.50
Albumin (g/dL) 3.7 ± 0.5 3.8 ± 0.4 3.8 ± 0.3 0.52
Hemoglobin (g/dL) 10.0 ± 1.5 10.8 ± 1.4 10.0 ± 1.5 0.48
Residual renal function 2.0 ± 0.4 2.4 ± 0.9 2.1 ± 0.5 0.91
APD (%) 6 (40%) 1 (12.5) 9 (37.5%) 0.37
Glucose load (kg)a 52.3 ± 49.4 103.8 ± 102.1 77.1 ± 95.2 0.37
PD duration (months) 15.9 ± 13.9 20.2 ± 23.0 15.9 ± 11.9 0.82
Total duration of dialysate exposure (months)b 12.4 ± 14.7 20.1 ± 23.1 14.3 ± 12.0 0.44
Dwelling timec 0.023*
Group 1 (%) 10 (66.7%) 1 (12.5) 5 (20.8%)
Group 2 (%) 3 (20%) 3 (37.5) 9 (37.5%)
Group 3 (%) 2 (13.3%) 4 (50%) 10 (41.7%)
Peritonitis (times) 0.8 ± 1.7 1.0 ± 1.5 0.4 ± 1.0 0.38
RAAS inhibitor (%) 24.0% 15.0% 33.1% 0.46
Statin (%) 25.3% 16.2% 20.0% 0.93
Abbreviations: EMT epithelial-to-mesenchymal transitioning, BMI body mass index, APD automatic peritoneal dialysis, PD peritoneal dialysis, RAAS inhibitor
renin-angiotensin-aldosterone system inhibitor.
Notes: aTotal peritoneal glucose exposure (kg); bTotal peritoneum dialysate contact time; cGroup 1: daily dwelling time <24 h (ranging from 8–20 h), Group 2: daily
dwelling time of 24 h with icodextrin-containing solution once daily, and Group 3: daily dwelling time of 24 h with all conventional dialysates; and *P < 0.05.
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also confirmed in vitro, and primary MC cultures were
incubated at different dwelling times (Figure 3). Figure 4
demonstrates that the percentage of fibroblast-like MCs
progressively increased when the dwelling time became
longer, i.e. on day 6 (Figure 4A-g, h, i). Phalloidin-labeled
staining showed that on day 6, the F-actin distribution of
the 8 (Figure 4B-g) and 16 h (Figure 4B-h) groups ap-
peared similar to that of the PBS group. However, in the
24 h group, most MCs had shrunk (Figure 4B-j), and the
remaining MCs were fibroblast-like (Figure 4B-i).
In addition, an increase in dwelling time induced a sig-
nificant decrease in E-cadherin expression (Figure 5A)
on day 3 (PBS vs. 24 h: P < 0.05; 8 h vs. TGF-β1: P <
0.01; PBS vs. TGF-β1: P < 0.005).Taken together, these
results indicate a shorter dwelling time may ameliorate
the EMT of MCs.
Cell survival was evaluated and determined indirectly by
the cell counts, (Figure 5B). On day 3, the 24 h group dem-
onstrated significantly lower cell counts compared to the
PBS group (P < 0.05). On day 6, the 16 and 24 h groups
demonstrated significantly lower cell counts compared to
the PBS group (PBS vs. 16 h: P < 0.05; PBS vs. 24 h: P <
0.01). Additionally, the 24 h group also had a significantly
lower cell count compared to the TGF-β1 group (P < 0.05).These indicate that a shorter dwelling time provides a bet-
ter environment for MC survival, as it may induce less
EMT-related stress.
Discussion
The EMT of peritoneal MCs plays an important role in
peritoneal membrane dysfunction [10,13,14]. However,
there is limited information and no consistent result
regarding the clinical parameters associated with EMT
(Additional file 1: Table S1) [10,12,14-18]. This may be re-
lated to the fact that there are no standard and objective
criteria for the classification of EMT of MCs from effluents
because of classifying the EMT of MCs only according to
morphology is both subjective and unreliable. In previous
studies, only a type of dialysate, PD duration, and periton-
itis/hemoperitoneum have been found to have a potential
association with EMT [10,15-17]. However, the results on
PD duration and episodes of peritonitis/hemoperitoneum
differed between studies, and only dialysates containing low
GDPs concentrations have been shown to prevent EMTab-
solutely [15,17,18]. To our knowledge, no previous study
has investigated whether dwelling time influences the EMT
of MCs. In a present study, we established “standard and
objective” criteria for the classification of EMT. In addition
to morphology, we classified MCs from effluents also
Table 2 Univariate and multivariate ordinal logistic regression analyses for determining the predictive factors of
epithelial-to-mesenchymal transition
Univariate Multivariated
OR (95% CI) P valve OR (95% CI) P valve
Age (year) 0.95 (0.89-1.00) 0.049* 0.94 (0.88-1.00) 0.08
Gender 0.59 (0.19-1.79) 0.35
BMI (kg/m2) 1.07 (0.93-1.23) 0.29
Diabetes Mellitus (yes/no) 2.29 (0.75-6.98) 0.14 0.29 (0.07-1.26) 0.10
Hypertension (yes/no) 0.36 (0.06-2.00) 0.25
Albumin (g/dL) 2.2 (0.53-9.45) 0.26
Hemoglobin (g/dL) 1.00 (0.71-1.41) 0.98
Residual renal function 1.00 (0.08-1.27) 0.98
APD (yes/no) 1.00 (0.32-3.16) 0.98
Glucose load (Kg)a 1.06 (0.86-1.31) 0.53
PD duration (months) 0.99 (0.96-1.02) 0.61
Total duration of dialysate exposure (months)b 1.00 (0.99-1.00) 0.37 1.00 (0.99-1.00) 0.61
Dwelling time (grouping)c
Group 2 to 1 5.01 (1.22-20.56) 0.025* 7.37 (1.35-40.20) 0.021*
Group 3 to 1 6.54 (1.60-26.70) 0.009* 6.16 (1.20-31.49) 0.028*
Peritonitis (times) 0.78 (0.51-1.20) 0.26 0.68 (0.41-1.13) 0.14
RAAS inhibitor (yes/no) 2.02 (0.61-6.60) 0.24
Statin (yes/no) 0.94 (0.26-3.33) 0.92
Abbreviations: OR odds ratio, CI confidence intervals, BMI body mass index, APD automatic peritoneal dialysis, PD peritoneal dialysis, RAAS inhibitor renin-
angiotensin-aldosterone system inhibitor.
Notes: aTotal peritoneal glucose exposure (kg); bTotal peritoneum dialysate contact time; cGroup 1: daily dwelling time <24 h (ranging from 8–20 h), Group 2:
daily dwelling time of 24 h with icodextrin-containing solution once daily, and Group 3: daily dwelling time of 24 h with all conventional dialysate; and *P < 0.05;
dSignificant predictors (P < 0.2) in univariate analysis and other possible factors that may influence EMT of the MCs, such as total dialysate exposure duration,
and episodes of peritonitis were included in the multivariate analysis.
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18 is one of the most common EMT markers [11,13,22].
We believed this method to be more objective, and based
on these criteria, we determined that the dwelling time per
se affects peritoneal EMT. Patients who received continu-
ous bio-incompatible PD therapy (i.e. dwelling time of 24 h/
day) had greater EMT tendency, and this tendency was
not suppressed by one exchange per day of icodextrin-
containing solution. This result means that persistent con-
tact with bio-incompatible dialysate leads to MCs suffer-
ing from continuous stress and as a result, causes EMT.
On the other hand, intermittent contact with bio-
incompatible dialysate (dwelling time ranging from 8 to
20 hours) may allow MCs to organize a repair process
during the resting period. One concern is that RRF may
be one factor which can influence EMT, so we also took it
into analysis. The result showed that RRF was not a factor
influence EMT.
Herein, we replaced the PD duration with the total dur-
ation of dialysate exposure because we thought that the lat-
ter may be more correlated with total dialysate contact time
rather than the former. We also considered that the contro-
versial findings on the effects of PD duration on EMT inprevious studies may have been due to the above stated rea-
son. Ultimately, we found there to be no correlation be-
tween the total duration of dialysate exposure and EMT.
It has been proven that patients who use more bio-
compatible dialysate containing lower amounts of GDPs
have a lower occurrence of peritoneal EMT [15,17,18]. On
the contrary, the effect of icodextrin-containing solution on
EMT still unknown. In our study, there was no difference
in the occurrence of the EMT of MCs in either subjects
who received continuous dialysis with a daily dwelling time
of up to 24 h or in those who were interrupted with a daily
exchange of icodextrin-containing solution. This may be re-
lated to a moderate amount of GDPs and the acidic feature
of the icodextrin-containing solution, which may activate
inflammatory cytokines, chemokines and promote EMT
[23,24]. In addition, glucose load also showed no correl-
ation with the EMT process. Taken together, this may mean
that although glucose may induce the EMT process [25], it
may play an insignificant role.
There are still some limitations remaining that should
be noted. First, there is still some controversy about
whether the MCs collected from effluent can represent
the MCs that are still attached at the peritoneum. It has
Figure 4 The effects of different dwelling times on cell morphology and cytoskeleton organization. A) (a & e) On day 3, the mesothelial
cells (MCs) appeared to be epithelioid-like in the phosphate-buffered saline (PBS) group and fibroblast-like in the transforming growth factor-β1
(TGF-β1) group. (b, c, d) There were some fibroblast-like MCs in the 8, 16, and 24 hour groups, and there were no significant differences between
them. (g, h, i) Fibroblast-like MCs progressively increased after incubation with conventional dialysate for 6 days, especially in the case of the
24 hour group, where most of the MCs became fibroblast-like. Meanwhile, the cell count decreased with longer daily dwelling times, especially in
the case of the 24 hour group (×200; N = 3). B) MC cytoskeletons were stained with anti-F-actin antibodies on days 3 and 6. (a & e) On day 3, the
actin cytoskeleton in the cortical band of the PBS group was compared to the fibroblast-like cytoskeleton of the TGF-β1 group. (b, c, d) The intracellular
F-actin distribution of the 8, 16, and 24 hour groups ranged between the morphology of the PBS and TGF-β1 groups. However, there were no
significant differences between these three groups. (f & k) On day 6, the actin cytoskeleton in the cortical band of the PBS group was compared
to the fibroblast-like cytoskeleton of the TGF-β1 group. (g & h) The intracellular F-actin distributions of the 8 and 16 hour groups were similar to
those of the PBS group. (i & j) However, most MCs shrunk in the 24 hour group, and the remainder of the MCs had a fibroblast-like cytoskeleton
similar to that exhibited in the TGF-β1 group (N = 3).
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method for such assessments [26]. However, the biopsy
procedure is difficult and impractical in clinical practice
for most clinically stable PD patients. Additionally, the
tissues obtained from these biopsies represent only a
very small part of the entire peritoneum. In contrast, the
MCs from the effluent are easily collected, and there are
no complications in practice. Furthermore, increasing
data from in vivo and in vitro studies all indicate that
MCs from the effluent are representative of the MC
population remaining on the peritoneum [8,10,12]. The
second limitation is that the culture failure rate from the
effluent was quite high. We think this may be due to the
fact that the number of cells collected from the dialysate
effluent was always less than the cell culture require-
ment because when the MC culture was from omentum;
our success rate was almost 100%. The third limitation
is that few incident PD patients were enrolled in ourstudy. This may suggest that we couldn’t completely ex-
clude the effect of PD duration. Another limitation is
that in our in vitro study model, persistent high concen-
tration of glucose, pH and GDP in culture medium is
different with markedly decreased concentration of
glucose and increased pH with time during one dwell
in PD patients. We think in vivo study in future will be
a good solution to this problem and can prove more
solid evidence [26]. Finally, in our study, we didn’t pro-
vide the mechanisms to explain which the most im-
portant factor on EMT is in short dwelling PD
including glucose, GDP, and dialysate pH. This indi-
cates the necessary for further study in the future.
Conclusions
We provide evidence that daily dwelling time per se
has a significant impact on the occurrence of EMT of
MCs. Because there’s no evidence showing that
Figure 5 The effects of daily different dwelling times on cellular protein expression and cell survival. Expression of E-cadherin in mesothelial
cells (MCs) was assessed on day 3, and cell counts were determined on days 3 and 6. A) The expression of E-cadherin, exhibited significant
down-regulation with increasing dwell time (N = 4). B) The cell count decreased with a longer daily dwell time, where the maximal decrease
was evident in the 24 hour group. On day 3, the 24 hour group demonstrated a significantly lower cell count compared to the phosphate-buffered
saline (PBS) group. On day 6, the 16 and 24 hour groups demonstrated a significantly lower cell count compared to the PBS group. Additionally, the
24 hour group also demonstrated a significantly lower cell count compared to the transforming growth factor-β1 (TGF-β1) group (N = 4) (*P < 0.05;
**P < 0.01; ***P < 0.005).
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people who don’t have ultrafiltration or clearance
problems, perhaps these patients should avoid 24 h of
continuous dialysis in the future.
Additional file
Additional file 1: Table S1. Literature review of all studies on the
factors associated with epithelial-to-mesenchymal transition of mesothelial
cells during peritoneal dialysis.
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